Ju Fu Tang Biotech Holdings Co., Ltd (HKG:8217)

Revenue by Segment

Financials in millions HKD. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
Provision of Civil Engineering and Renovation Works	35.44M	-	-	-	-
Health Technology Business	2.11M	-	-	-	-
Provision of Civil Engineering Works	-	36.20M	35.14M	104.60M	92.75M
Provision of Civil Engineering Works Growth	-	3.02%	-66.40%	12.77%	-44.89%
Total	37.56M	36.20M	35.14M	104.60M	92.75M
Total Growth	3.74%	3.02%	-66.40%	12.77%	-44.89%

Revenue by Geography

Financials in millions HKD. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
Hong Kong	35.44M	36.20M	35.14M	104.60M	92.75M
Hong Kong Growth	-2.10%	3.02%	-66.40%	12.77%	-44.89%
People's Republic of China (the PRC)	2.11M	-	-	-	-
Total	37.56M	36.20M	35.14M	104.60M	92.75M
Total Growth	3.74%	3.02%	-66.40%	12.77%	-44.89%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jul 11, 2026

Data Sources Report a data error